The CMS Two-Midnight rules continues to prompt questions.
Well, I finally read through the 1,394-page 2022 Outpatient Prospective Payment System (OPPS) Final Rule, and luckily, there were no great surprises.
As I mentioned previously, the Centers for Medicare & Medicaid Services (CMS) is now keeping the Inpatient-Only List alive, and adding back to the List most of those procedures removed this year. It took CMS 100 pages to discuss this policy change. When CMS finalized the two-midnight rule, that took only 47 pages. Here we are, eight years since the adoption of the two-midnight rule, and there are still questions – so perhaps having more pages dedicated to this reversal will lead to fewer questions in the future. I will go into detail about the changes in my December RACmonitor webinar.
A couple of other things in the rule did stand out and are worth mentioning. First, there are 110 different skin substitutes used for skin grafting. Who knew? Sounds like going to the olive oil aisle in the grocery store. Second, as usual, there were a bunch of new devices, with providers asking for approval for device pass-through payments, wherein the hospital gets additional money added to the outpatient payment if the device is used. This is the outpatient version of the new technology add-on payment system for inpatient admissions.
As with the Inpatient Prospective Payment System (IPPS) Final Rule, CMS denied approval for the device that scrubs the colon clean during colonoscopy. Overall, they denied 50 percent of the devices for which pass-through payments were requested.
Now, what happens when devices get turned down? Well, one of two things: the hospital and doctors evaluate the cost, realize there is no added payment, and choose to use it or not, depending on its potential benefit – or the manufacturer lowers the cost so that providers will find the cost-benefit ratio more beneficial and start purchasing it. That’s another side of hospitals that is little-discussed, but crucial: our colleagues in the supply chain.
They are also adopting an interesting quality measure: the rate of patient recalls for further imaging after a screening mammogram. It’s a fascinating issue – if there is too much additional imaging done, you subject patients to unnecessary radiation, cost, and anxiety. If there is too little done, you risk missing treatable cancers. But here is the problem: just like with observation, there is no right rate, because every facility’s patient population is different.
CMS even admits that, but they state that expert consensus and peer-reviewed literature support their chosen range of 5 to 12 percent. While this rate may be what is recommended by experts or what is commonly seen in hospitals, there is no data to support improved patient outcomes for facilities within that range. Will hospitals below that rate have to start recalling patients with normal exams, simply to avoid a penalty? Will hospitals above that rate recall fewer patients and miss cancers? Establishing quality measures without robust clinical outcome data has the potential to produce more harm than good.
Finally, there has been a lot of talk about the significant Medicare Part B rate increases announced Friday – and lots of bad information. Here is the truth. The Food and Drug Administration (FDA) approved Aduhelm, the new Alzheimer’s drug that costs $56,000 a year and is given intravenously, requiring regular brain imaging, under the accelerated approval process this year. So far usage has been minimal, but CMS was required to raise Part B rates, because they don’t know how many patients will get this treatment in 2022. They admit that they are planning for the worst-case scenario, that it is used a lot, and that it will cost Part B a lot of money. That’s how budgeting works. We can only hope that doctors realize that the medication has yet to demonstrate a clinically significant positive result, and won’t order it – and then 2023 premiums can go down.
Programming Note: Listen to Dr. Ronald Hirsch as he makes his Monday rounds on Monitor Mondays, 10 Eastern, sponsored by R1RCM.
In the CY 2026 OPPS/ASC Final Rule, the Centers for Medicare & Medicaid Services (CMS) formally finalized the removal of the Screening for Social Drivers
The 2026 Medicare Physician Schedule Final Rule includes several distinct policy changes in which the Centers for Medicare & Medicaid Services (CMS) modifies how it
Please log in to your account to comment on this article.
Expert presenters Kathy Pride, RHIT, CPC, CCS-P, CPMA, and Brandi Russell, RHIA, CCS, COC, CPMA, break down complex fracture care coding rules, walk through correct modifier application (-25, -57, 54, 55), and clarify sequencing for initial and subsequent encounters. Attendees will gain the practical knowledge needed to submit clean claims, ensure compliance, and stay one step ahead of payer audits in 2026.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
Get clear, practical answers to Medicare’s most confusing regulations. Join Dr. Ronald Hirsch as he breaks down real-world compliance challenges and shares guidance your team can apply right away.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
